课题基金 / 基金详情

Bronchopulmonary Dysplasia – A Regenerative Medicine Approach

Bronchopulmonary Dysplasia – A Regenerative Medicine Approach
支气管肺发育不良 — 再生医学方法
批准号:
nhmrc : 1083744
负责人:
A/Pr Daniel Chambers
金额:
$32.03万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31

项目摘要

项目成果

A/Pr Daniel Chambers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bronchopulmonary dysplasia is a major leading cause of morbidity and mortality in premature babies. There is no cure. We have previously shown that amnion epithelial cells can reduce the extent of lung damage during early stages of lung development. We aim to understand how amnion cells can promote repair by interacting with existing cell types in order to restore normal lung structure and function. The outcomes from this study will help design clinical trials and develop new therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ambulatory oxygen for interstitial lung disease
  • 批准号:
    nhmrc : 1139953
  • 项目类别:
    Project Grants
  • 资助金额:
    $101.67万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
Modulation of lung regeneration and remodeling by the innate immune system.
  • 批准号:
    nhmrc : 1147256
  • 项目类别:
    Project Grants
  • 资助金额:
    $39.42万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
Centre for Research Excellence in Pulmonary Fibrosis
  • 批准号:
    nhmrc : 1116371
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $170.92万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
Conquering the final frontier in lung transplantation - Mesenchymal stromal cell therapy for chronic lung allograft dysfunction
  • 批准号:
    nhmrc : 1103789
  • 项目类别:
    Project Grants
  • 资助金额:
    $130.38万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
国内基金
海外基金
ANO5基因突变导致Gnathodiaphyseal dysplasia的发病机制研究
  • 批准号:
    81570958
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    胡颖
  • 依托单位: